|
|||
2012-05-23 19:24:28 CEST 2012-05-23 19:25:18 CEST REGULATED INFORMATION Össur hf. - Changes in company's own sharesOssur Hf : Share options grantedAnnouncement from Össur hf. No.20/2012 Reykjavik, 23 May 2012 Today, Össur hf. has granted 500,000 share options to Dr. Thorvaldur Ingvarsson who will become Executive Vice President of R&D at Össur as of 30 June 2012. The exercise price is DKK 8.59, i.e. the Company's average share price on NASDAQ OMX Copenhagen 20 trading days prior to the grant date. First exercise date is 23 May 2015. Dr. Ingvarsson holds no shares in Össur. The share options are granted in accordance with the Company's share option scheme implemented on 24 April 2012. Further details on the share option scheme, including the key terms and conditions, can be found in the Company's announcement No. 16/2012 published on 24 April 2012. Össur press releases by e-mail If you wish to receive Össur press releases by e-mail please register at the following web-site: http://www.ossur.com/investormailings. About Össur Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy, including the Flex-Foot Cheetah carbon fiber running prostheses used by"The Blade Runner," renowned double-amputee sprinter Oscar Pistorius. A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com [HUG#1614469] |
|||
|